D360 User Group Meeting

Join us and the worldwide D360 team to learn how D360 is being leveraged every day to improve research and implement best practices in data utilization. The meeting will include presentations from D360 users, and updates on the D360 vision and roadmap. Spots are limited, so be sure to save your seat soon! Details on … Continued

Industry Metrics for CDISC Terminology

Despite continuous development of, and the quarterly updates to, CDISC Controlled Terminology, there is still a need for study-specific extensions to standard codelists. Often, extensions to standard terminology are incorrect. For example, some users falsely believe that any new terms can be added to an extensible codelist and related data validation is not needed if … Continued

Learn How Discovery Data Technology Enables Faster Discovery Research

Thu, Nov 4, 2021 1:00 PM – 2:00 PM EDT Drug discovery research requires understanding complex chemical, biological, logistical, and computational data from a wide variety of data sources. A key challenge for discovery scientists is efficiently accessing the most relevant data from internal and external data sources in a cohesive project data view. Manual … Continued

Simcyp for Accelerating Polymer Drug Development

November 30th, 4-5pm JST How does Simcyp Biologics work? By Felix Stader, Sr. Research Scientist, Res&Dev, Certara In the session, we will look at the capabilities of the Simcyp Simulator to predict the pharmacokinetics of therapeutic proteins. The structure and the fundamental underlying assumptions of the model will be covered as well as different clearance … Continued

Overview of the Phoenix platform – Applications for CAR-T cell modeling

Thu, Oct 28th, 9:00 am – 10:30 am CST (China Standard Time) Phoenix software is the gold standard for pharmacokinetic/pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation. The platform is increasingly recognized as the key software for reviewing new drugs and biologics marketing applications. In this webinar, Certara and guest speakers will introduce you to the … Continued

Model-based DDI Extrapolation Strategy from Adults to Children – A Case Study with Risdiplam

Risdiplam (EVRYSDI) is approved for the treatment of patients with spinal muscular atrophy ≥ 2 months old. CYP3A-mediated DDI risk in pediatric patients was evaluated by physiologically-based pharmacokinetic (PBPK) modelling and informed the label. This talk will illustrate a modeling strategy for the extrapolation of DDIs from adults to children covering: Development of a patient-specific … Continued

How D360 platform helps your decisions for small molecule and biologic drug development and a preclinical translational research

9:00 am – 10:00 am CST (China Standard Time) Drug development requires understanding of complex chemical, biological, logical, and computational data from multiple data sources. Whether you are accessing data from a single source or need a more comprehensive enterprise data integration solution, the D360 toolkit and additional products provide you with the flexibility to … Continued

1 of 20
Back to top
Powered by Translations.com GlobalLink OneLink Software